{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T18:20:32Z","timestamp":1789582832098,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T00:00:00Z","timestamp":1644624000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["arthroplastytoday.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Arthroplasty Today"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.artd.2022.02.003","type":"journal-article","created":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T21:30:03Z","timestamp":1647293403000},"page":"133-139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Bisphosphonates in Total Joint Arthroplasty: A Review of Their Use and Complications"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9633-5336","authenticated-orcid":false,"given":"Christopher L.","family":"McDonald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Lemme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward J.","family":"Testa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0745-2267","authenticated-orcid":false,"given":"Roy","family":"Aaron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3526-1465","authenticated-orcid":false,"given":"Davis A.","family":"Hartnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric M.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.artd.2022.02.003_bib1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2106\/00004623-199401000-00009","article-title":"Distal loss of femoral bone following total knee arthroplasty. Measurement with visual and computer-processing of roentgenograms and dual-energy x-ray absorptiometry","volume":"76","author":"Robertson","year":"1994","journal-title":"J\u00a0Bone Joint Surg Am"},{"issue":"7","key":"10.1016\/j.artd.2022.02.003_bib2","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.arth.2019.03.044","article-title":"Osteoporosis is common and undertreated prior to total joint arthroplasty","volume":"34","author":"Bernatz","year":"2019","journal-title":"J\u00a0Arthroplasty"},{"issue":"2","key":"10.1016\/j.artd.2022.02.003_bib3","first-page":"105","article-title":"Bone mineral density changes after total knee replacement in women over the age of 65","volume":"20","author":"Yoon","year":"2013","journal-title":"J\u00a0Bone Metab"},{"issue":"1","key":"10.1016\/j.artd.2022.02.003_bib4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11999-009-0945-0","article-title":"The epidemiology of revision total knee arthroplasty in the United States","volume":"468","author":"Bozic","year":"2010","journal-title":"Clin Orthop Relat Res"},{"issue":"1","key":"10.1016\/j.artd.2022.02.003_bib5","doi-asserted-by":"crossref","first-page":"128","DOI":"10.2106\/JBJS.H.00155","article-title":"The epidemiology of revision total hip arthroplasty in the United States","volume":"91","author":"Bozic","year":"2009","journal-title":"J\u00a0Bone Joint Surg Am"},{"issue":"5","key":"10.1016\/j.artd.2022.02.003_bib6","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.jbiomech.2014.12.021","article-title":"Long-term implant fixation and stress-shielding in total hip replacement","volume":"48","author":"Sumner","year":"2015","journal-title":"J\u00a0Biomech"},{"key":"10.1016\/j.artd.2022.02.003_bib7","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00003086-199707000-00016","article-title":"Wear particulate species and bone loss in failed total joint arthroplasties","volume":"340","author":"Kadoya","year":"1997","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.artd.2022.02.003_bib8","series-title":"Classic papers in Orthopaedics","first-page":"51","article-title":"Porous-coated hip replacement. The factors governing bone ingrowth, stress shielding, and clinical results","author":"Banaszkiewicz","year":"2014"},{"issue":"258","key":"10.1016\/j.artd.2022.02.003_bib9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00003086-199009000-00013","article-title":"Osteolysis in alloarthroplasty of the hip. The role of ultra-high molecular weight polyethylene wear particles","author":"Willert","year":"1990","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.artd.2022.02.003_bib10","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/BLO.0b013e31804b4147","article-title":"The biology of aseptic osteolysis","volume":"460","author":"Holt","year":"2007","journal-title":"Clin Orthop Relat Res"},{"issue":"276","key":"10.1016\/j.artd.2022.02.003_bib11","first-page":"126","article-title":"Wear of polyethylene in total joint replacements. Observations from retrieved PCA knee implants","author":"Wright","year":"1992","journal-title":"Clin Orthop Relat Res"},{"issue":"4","key":"10.1016\/j.artd.2022.02.003_bib12","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1345\/aph.1E357","article-title":"Discovery, clinical development, and therapeutic uses of bisphosphonates","volume":"39","author":"Licata","year":"2005","journal-title":"Ann Pharmacother"},{"issue":"274","key":"10.1016\/j.artd.2022.02.003_bib13","first-page":"124","article-title":"The relationship between stress shielding and bone resorption around total hip stems and the effects of flexible materials","author":"Huiskes","year":"1992","journal-title":"Clin Orthop Relat Res"},{"issue":"3","key":"10.1016\/j.artd.2022.02.003_bib14","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s12178-017-9423-6","article-title":"Bundled payments in total joint replacement: keeping our care affordable and high in quality","volume":"10","author":"McLawhorn","year":"2017","journal-title":"Curr Rev Musculoskelet Med"},{"issue":"16","key":"10.1016\/j.artd.2022.02.003_bib15","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1172\/JCI118722","article-title":"Perspectives bisphosphonates: mechanisms of action","volume":"97","author":"Rodan","year":"1996","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"10.1016\/j.artd.2022.02.003_bib16","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1359\/jbmr.1998.13.4.581","article-title":"Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras","volume":"13","author":"Luckman","year":"1998","journal-title":"J\u00a0Bone Miner Res"},{"issue":"3","key":"10.1016\/j.artd.2022.02.003_bib17","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1006\/bbrc.2002.6510","article-title":"Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts","volume":"291","author":"Viereck","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"issue":"24","key":"10.1016\/j.artd.2022.02.003_bib18","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1016\/j.biomaterials.2007.04.024","article-title":"Anabolic effects of bisphosphonates on peri-implant bone stock","volume":"28","author":"von Knoch","year":"2007","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.artd.2022.02.003_bib19","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2106\/00004623-200202000-00010","article-title":"Alendronate does not inhibit early bone apposition to hydroxyapatite-coated total joint implants a preliminary study","volume":"84","author":"Mochida","year":"2002","journal-title":"J\u00a0Bone Joint Surg Am"},{"issue":"51","key":"10.1016\/j.artd.2022.02.003_bib20","doi-asserted-by":"crossref","first-page":"e13346","DOI":"10.1097\/MD.0000000000013346","article-title":"Efficacy of risedronate in improving bone mineral density in patients undergoing total hip arthroplasty","volume":"97","author":"Su","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.artd.2022.02.003_bib21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jbiomech.2018.04.041","article-title":"A\u00a0long-lasting bisphosphonate partially protects periprosthetic bone, but does not enhance initial stability of uncemented femoral stems: a randomized placebo-controlled trial of women undergoing total hip arthroplasty","volume":"75","author":"Aro","year":"2018","journal-title":"J\u00a0Biomech"},{"key":"10.1016\/j.artd.2022.02.003_bib26","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ijsu.2017.08.559","article-title":"Effect of zoledronic acid on reducing femoral bone mineral density loss following total hip arthroplasty: a meta-analysis from randomized controlled trails","volume":"47","author":"Gao","year":"2017","journal-title":"Int J Surg"},{"issue":"7","key":"10.1016\/j.artd.2022.02.003_bib30","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/s00198-018-4488-7","article-title":"Bisphosphonates for the preservation of periprosthetic bone mineral density after total joint arthroplasty: a meta-analysis of 25 randomized controlled trials","volume":"29","author":"Shi","year":"2018","journal-title":"Osteoporos Int"},{"issue":"11","key":"10.1016\/j.artd.2022.02.003_bib23","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.2106\/00004623-200311000-00009","article-title":"The effect of alendronate on bone mineral density in the distal part of the femur and proximal part of the tibia after total knee arthroplasty","volume":"85","author":"Wang","year":"2003","journal-title":"J\u00a0Bone Joint Surg Am"},{"issue":"2","key":"10.1016\/j.artd.2022.02.003_bib31","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2106\/JBJS.D.01772","article-title":"Effect of bisphosphonates on periprosthetic bone mineral density after total joint arthroplasty. a meta-analysis","volume":"87","author":"Bhandari","year":"2005","journal-title":"J\u00a0Bone Joint Surg Am"},{"issue":"2","key":"10.1016\/j.artd.2022.02.003_bib33","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.arth.2015.09.005","article-title":"Lower total knee arthroplasty revision risk associated with bisphosphonate use, even in patients with normal bone density","volume":"31","author":"Namba","year":"2016","journal-title":"J\u00a0Arthroplasty"},{"issue":"7","key":"10.1016\/j.artd.2022.02.003_bib34","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1007\/s00167-018-5333-4","article-title":"The use of bisphosphonates after joint arthroplasty is associated with lower implant revision rate","volume":"27","author":"Ro","year":"2019","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"10.1016\/j.artd.2022.02.003_bib24","doi-asserted-by":"crossref","first-page":"d7222","DOI":"10.1136\/bmj.d7222","article-title":"Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study","volume":"343","author":"Prieto-Alhambra","year":"2011","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.artd.2022.02.003_bib28","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13018-018-0808-z","article-title":"The efficiency of risedronate in reducing bone resorption after total hip arthroplasty: a meta-analysis of randomized control trials at a minimum of 6 months\u2019 follow-up","volume":"13","author":"Yang","year":"2018","journal-title":"J\u00a0Orthop Surg Res"},{"issue":"10","key":"10.1016\/j.artd.2022.02.003_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0139927","article-title":"Bisphosphonate use and risk of implant revision after total hip\/knee arthroplasty: a meta-analysis of observational studies","volume":"10","author":"Teng","year":"2015","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.artd.2022.02.003_bib25","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s00198-019-05005-7","article-title":"Effects of zoledronic acid on bone mineral density around prostheses and bone metabolism markers after primary total hip arthroplasty in females with postmenopausal osteoporosis","volume":"30","author":"Zhou","year":"2019","journal-title":"Osteoporos Int"},{"issue":"11","key":"10.1016\/j.artd.2022.02.003_bib32","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1007\/s11999-015-4263-4","article-title":"Association of bisphosphonate use and risk of revision after THA: outcomes from a US total joint replacement registry","volume":"473","author":"Khatod","year":"2015","journal-title":"Clin Orthop Relat Res"},{"issue":"6","key":"10.1016\/j.artd.2022.02.003_bib22","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s00223-002-1022-9","article-title":"Effect of alendronate on periprosthetic bone loss after total knee arthroplasty: a one-year, randomized, controlled trial of 19 patients","volume":"71","author":"Soininvaara","year":"2002","journal-title":"Calcif Tissue Int"},{"issue":"4","key":"10.1016\/j.artd.2022.02.003_bib27","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/os.12513","article-title":"Efficiency of zoledronic acid in inhibiting accelerated periprosthetic bone loss after cementless total hip arthroplasty in osteoporotic patients: a prospective, cohort study","volume":"11","author":"Fu","year":"2019","journal-title":"Orthop Surg"},{"issue":"17","key":"10.1016\/j.artd.2022.02.003_bib29","doi-asserted-by":"crossref","first-page":"e0379","DOI":"10.1097\/MD.0000000000010379","article-title":"Effect of risedronate on femoral periprosthetic bone loss following total hip replacement: a systematic review and meta-analysis","volume":"97","author":"Ren","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"10.1016\/j.artd.2022.02.003_bib36","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1002\/art.38789","article-title":"Oral bisphosphonate use and total knee\/hip implant survival: validation of results in an external population-based cohort","volume":"66","author":"Prieto-Alhambra","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.artd.2022.02.003_bib37","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.arth.2012.08.007","article-title":"Effect of zoledronic acid on reducing femoral bone mineral density loss following total hip arthroplasty","volume":"28","author":"Scott","year":"2013","journal-title":"J\u00a0Arthroplasty"},{"issue":"3","key":"10.1016\/j.artd.2022.02.003_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2106\/JBJS.RVW.N.00062","article-title":"Atypical fractures of the femur: evaluation and treatment","volume":"3","author":"Blood","year":"2015","journal-title":"JBJS Rev"},{"issue":"5","key":"10.1016\/j.artd.2022.02.003_bib39","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3109\/17453674.2015.1036339","article-title":"Bisphosphonate-associated peri-implant fractures: a new clinical entity? A series of 10 patients with 11 fractures","volume":"86","author":"Lee","year":"2015","journal-title":"Acta Orthop"}],"container-title":["Arthroplasty Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352344122000413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352344122000413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:10:02Z","timestamp":1762452602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352344122000413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":39,"alternative-id":["S2352344122000413"],"URL":"https:\/\/doi.org\/10.1016\/j.artd.2022.02.003","relation":{},"ISSN":["2352-3441"],"issn-type":[{"value":"2352-3441","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bisphosphonates in Total Joint Arthroplasty: A Review of Their Use and Complications","name":"articletitle","label":"Article Title"},{"value":"Arthroplasty Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.artd.2022.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc. on behalf of The American Association of Hip and Knee Surgeons.","name":"copyright","label":"Copyright"}]}}